Article 1 to 3 out of 3 concerning Abbott Molecular Inc.
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response(11 Mar 2008) Abbott's FISH Technology Provides Analytical Tool with Potential to Assess Clinical Response to Lung Cancer Treatment in Patients with Non-Small-Cell Lung Cancer Abbott announced that its molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals, Inc. to develop a gene test to potentially assess the clinical benefit of Tarceva(R) ...
Epigenomics AG: strategic in vitro diagnostics partnership with Abbott Molecular(27 Sep 2007) Collaboration focuses on development and global commercialization of a molecular diagnostic test for the early detection of colorectal cancer.Abbott obtains non-exclusive worldwide rights to Epigenomics' proprietary DNA methylation biomarker Septin ...
Agilent Technologies Obtains Multicolor, CGH Microarray Licenses from Abbott Molecular(08 Sep 2006) Agilent Technologies Inc. announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression ...
Top
